nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—Erythema facial—Hydrochlorothiazide—nephrolithiasis	0.128	0.131	CcSEcCtD
Methylprednisolone—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0558	0.0572	CcSEcCtD
Methylprednisolone—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.053	0.0543	CcSEcCtD
Methylprednisolone—Trauma—Hydrochlorothiazide—nephrolithiasis	0.049	0.0502	CcSEcCtD
Methylprednisolone—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0349	0.0357	CcSEcCtD
Methylprednisolone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0288	0.0295	CcSEcCtD
Methylprednisolone—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0239	0.0245	CcSEcCtD
Methylprednisolone—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0218	CcSEcCtD
Methylprednisolone—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0211	0.0216	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0208	0.0213	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0199	CcSEcCtD
Methylprednisolone—Injury—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0189	CcSEcCtD
Methylprednisolone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.018	0.0184	CcSEcCtD
Methylprednisolone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0171	CcSEcCtD
Methylprednisolone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.016	0.0164	CcSEcCtD
Methylprednisolone—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0157	CcSEcCtD
Methylprednisolone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0153	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0153	CcSEcCtD
Methylprednisolone—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0151	CcSEcCtD
Methylprednisolone—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0147	CcSEcCtD
Methylprednisolone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0136	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0132	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0131	CcSEcCtD
Methylprednisolone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0131	CcSEcCtD
Methylprednisolone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0128	CcSEcCtD
Methylprednisolone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0122	CcSEcCtD
Methylprednisolone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0117	0.012	CcSEcCtD
Methylprednisolone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0116	CcSEcCtD
Methylprednisolone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0107	CcSEcCtD
Methylprednisolone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0104	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00946	0.00969	CcSEcCtD
Methylprednisolone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00932	0.00954	CcSEcCtD
Methylprednisolone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0092	0.00941	CcSEcCtD
Methylprednisolone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00916	0.00938	CcSEcCtD
Methylprednisolone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00936	CcSEcCtD
Methylprednisolone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00896	0.00917	CcSEcCtD
Methylprednisolone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00868	0.00889	CcSEcCtD
Methylprednisolone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00868	0.00889	CcSEcCtD
Methylprednisolone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00865	0.00886	CcSEcCtD
Methylprednisolone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00858	0.00878	CcSEcCtD
Methylprednisolone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00839	0.00859	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00852	CcSEcCtD
Methylprednisolone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00819	0.00838	CcSEcCtD
Methylprednisolone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00812	0.00831	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00805	0.00824	CcSEcCtD
Methylprednisolone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00796	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00776	CcSEcCtD
Methylprednisolone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00753	0.00771	CcSEcCtD
Methylprednisolone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00747	0.00765	CcSEcCtD
Methylprednisolone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00733	0.0075	CcSEcCtD
Methylprednisolone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00734	CcSEcCtD
Methylprednisolone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00702	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00681	0.00697	CcSEcCtD
Methylprednisolone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00661	0.00677	CcSEcCtD
Methylprednisolone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00658	0.00673	CcSEcCtD
Methylprednisolone—NR3C1—urine—nephrolithiasis	0.00636	0.276	CbGeAlD
Methylprednisolone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00628	CcSEcCtD
Methylprednisolone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00611	CcSEcCtD
Methylprednisolone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00589	0.00603	CcSEcCtD
Methylprednisolone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00569	0.00583	CcSEcCtD
Methylprednisolone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00563	CcSEcCtD
Methylprednisolone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00529	0.00542	CcSEcCtD
Methylprednisolone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00537	CcSEcCtD
Methylprednisolone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00537	CcSEcCtD
Methylprednisolone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00534	CcSEcCtD
Methylprednisolone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00506	CcSEcCtD
Methylprednisolone—CYP3A4—urine—nephrolithiasis	0.00481	0.209	CbGeAlD
Methylprednisolone—NR3C1—nephron tubule—nephrolithiasis	0.00171	0.0742	CbGeAlD
Methylprednisolone—NR3C1—renal system—nephrolithiasis	0.00156	0.0675	CbGeAlD
Methylprednisolone—NR3C1—kidney—nephrolithiasis	0.0015	0.0652	CbGeAlD
Methylprednisolone—NR3C1—cortex of kidney—nephrolithiasis	0.00147	0.0635	CbGeAlD
Methylprednisolone—CYP3A4—renal system—nephrolithiasis	0.00118	0.051	CbGeAlD
Methylprednisolone—CYP3A4—kidney—nephrolithiasis	0.00114	0.0493	CbGeAlD
Methylprednisolone—ABCB1—nephron tubule—nephrolithiasis	0.000917	0.0397	CbGeAlD
Methylprednisolone—ABCB1—renal system—nephrolithiasis	0.000833	0.0361	CbGeAlD
Methylprednisolone—ABCB1—kidney—nephrolithiasis	0.000806	0.0349	CbGeAlD
Methylprednisolone—ABCB1—cortex of kidney—nephrolithiasis	0.000785	0.034	CbGeAlD
